This PTT-induced treatment led to a partial reduction in collagen I within the ECM, promoting deep infiltration of immune cells and antitumor drugs, boosting SF release to exert antivascular ability and suppress PD-L1 expression on tumor cells and TAMs through the RAS/RAF/ERK pathway, inducing the ICD effect. The gene discussed is CD274; the disease is neoplasm.